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Introduction {#sec1}
============

It has become increasingly clear that early life development is a critical and unique window of vulnerability during which environmental exposures influence cellular programming in ways that shape health and disease later in life. There is also growing evidence that maternal stressors and environmental factors affect not just the offspring\'s health, but also that of subsequent generations as well ([@bib29], [@bib64], [@bib66], [@bib72], [@bib73], [@bib79], [@bib83]). Exposure during pregnancy results in the developing fetus (F1) and its gametes (F2) being exposed. Changes in the F1 and F2 progeny are referred to as developmental and multigenerational effects, respectively. The F3 generation is the first generation with no exposure to the original insult to the pregnant mother; therefore changes in this generation represent transgenerational inheritance ([@bib71]). Recent reports of transgenerationally inherited adverse health effects of environmental exposures underscore the importance of this phenomenon to human health and disease ([@bib22], [@bib25], [@bib39]).

The majority of studies demonstrating transgenerational effects of environmental agents have examined their consequences on the reproductive, nervous, or endocrine systems ([@bib2], [@bib7], [@bib28], [@bib29], [@bib59], [@bib74]). In contrast, research on transgenerational inheritance rarely includes assessment of whether maternal exposures impinge on the function of the immune system. Yet, a properly functioning immune system is fundamentally important to individual and public health. Even slight alterations can reduce defenses against infections or diminish vaccine efficacy ([@bib17], [@bib26], [@bib76], [@bib84]). Thus, the consequences of maternal and early life exposures that alter the function of the immune system are broad reaching. Moreover, when it has been examined, developmental exposures to a range of common pollutants, pharmaceuticals, as well as maternal diet have been associated with changes in immune function later in life ([@bib10], [@bib19]). For instance, higher levels of dioxins and polychlorinated biphenyls (PCBs) in breast milk, cord, and infant blood correlate with increased respiratory tract infections and reduced responses to vaccination ([@bib30], [@bib36], [@bib54], [@bib76]). Animal studies reveal parallel events, showing that maternal and early life exposures durably change immune responses in the offspring ([@bib84], [@bib10]). For example, in mouse models, maternal treatment with the dioxin 2,3,7,8-tetrachlorodibenzo-*p*-dioxin (TCDD) perturbs T cell responses to influenza A virus (IAV) infection in offspring ([@bib12], [@bib81], [@bib85]). TCDD and other dioxins, as well as PCBs, are persistent organic pollutants. Moreover, many dioxins and PCBs, including TCDD, activate the aryl hydrocarbon receptor (AHR), an environment-sensing transcription factor that plays important, albeit not fully understood, roles in the development and function of the immune system ([@bib68], [@bib75]). In addition to pollutants, the AHR has a multitude of ligands ranging from pharmaceuticals to compounds in foods we eat to microbial by-products ([@bib32], [@bib55], [@bib58]); thus, we are regularly exposed to AHR ligands. Therefore, it is important to understand how exposure to AHR ligands impacts the immune system, including in subsequent generations. TCDD is the most potent and specific AHR agonist and provides a valuable tool to study how developmental activation of the AHR affects the immune system.

In addition to being expressed in cells of the immune system, the AHR is expressed in the reproductive tract, and there have been numerous studies examining the effects of TCDD on the reproductive system ([@bib14], [@bib45], [@bib88]). Developmental exposure to TCDD affects both the male and female reproductive systems. For instance, reduced sperm counts in males and higher incidence of endometriosis in females are among the effects observed in F1 offspring ([@bib14], [@bib61]). In addition to impacting germ cells and adult F1 offspring, there is also a growing literature base connecting F0 exposure to TCDD with transgenerational effects on both the male and female reproductive systems ([@bib13], [@bib15], [@bib50]). Taken together with studies showing that F0 TCDD exposure affects immune responses in F1 offspring ([@bib12], [@bib9], [@bib11], [@bib31], [@bib53], [@bib81], [@bib82], [@bib85]), we hypothesized that F0 TCDD exposure also causes transgenerational effects in the immune system.

Influenza A virus (IAV) is a common human pathogen that infects the respiratory system and causes infections that range in severity from moderate to fatal. Every year IAV infections are among the major causes of global morbidity and mortality ([@bib34], [@bib65]). Mouse models of infection with human IAV provide an experimental system with strong relevance to human health, and the murine immune response to IAV closely resembles that of humans ([@bib69]). In particular, successfully fighting acute primary IAV infection is CD8^+^ T cell dependent ([@bib78]). The T cell response to IAV occurs in two distinct sites: the lung-draining lymph nodes, such as the mediastinal lymph nodes (MLNs), and the respiratory tract. After encountering IAV in the respiratory tract, dendritic cells (DCs) emigrate to lymph nodes that drain the lung, where they activate naive CD8^+^ T cells. When they receive the correct signals, virus-specific CD8^+^ T cells undergo clonal expansion and differentiate into cytotoxic T lymphocytes (CTL), which migrate to the site of infection (i.e., lung), where they directly kill virally infected cells through the release of cytotoxic granules ([@bib40]).

In this study, we determined whether maternal (F0) exposure to the AHR agonist TCDD causes transgenerational effects on CD8^+^ T cell responses to IAV infection. Specifically, following maternal exposure to a low, environmentally relevant dose of TCDD ([@bib5], [@bib18]), we determined the frequency of responding CD8^+^ T cells in male and female offspring in the F1 and F3 generations, using well-established metrics of their activation, expansion, and differentiation into effector cells. By outcrossing F1 generation mice, we also sought to define whether the transgenerational effects on the immune system are preferentially passed through the maternal or paternal lineage. Delineating which aspects of the CD8^+^ T cell response to infection are affected across generations furthers our understanding of how environmental AHR ligands cause durable changes to T cell responses and also expands current knowledge of how developmental exposures can impinge on immune responses later in life.

Results {#sec2}
=======

To generate transgenerationally exposed cohorts, F0 dams were administered either vehicle or TCDD orally. The dose of TCDD used in this study does not cause overt toxicity to the dam or pups, nor does it alter immune organ cellularity in naive (unchallenged) offspring ([@bib81], [@bib85]). At maturity, non-sibling F1 offspring were bred to create the F2 generation, and then non-sibling, non-cousin F2 offspring were bred to create the F3 generation ([Figure 1](#fig1){ref-type="fig"}A, see [Transparent Methods](#mmc1){ref-type="supplementary-material"}). Consistent with prior reports ([@bib81], [@bib82]), maternal treatment with TCDD at this dose and on this schedule did not alter the time to parturition (time from vaginal plug discovery to birth), litter size, or sex ratio in F1 offspring ([Figure 1](#fig1){ref-type="fig"}B). Similarly, F0 exposure did not significantly change fertility and duration of pregnancy, as there were no differences in the time between pairing and birth in the F2 or F3 generations, nor were there differences in litter size or sex ratio among the offspring ([Figure 1](#fig1){ref-type="fig"}B).Figure 1Breeding Schematic and Reproductive Endpoints(A) Transgenerational breeding strategy: Pregnant C57/Bl6 dams were treated (p.o.) with either vehicle or TCDD (1 μg/kg) on GD0, 7, 14, and PND2. Separate sires were used for each dam. No culling of litters was performed, and littermates were housed in same-sex groups. Offspring sex was determined, and offspring were randomly assigned to groups for breeding or infection. 15--20 pairs of non-sibling F1 offspring were bred to create the F2 generation. F2 offspring were used to create the F3 generation.(B) The table summarizes pregnancy metrics, litter size, and sex ratio of offspring from the F1, F2, and F3 generations. Pregnancy metrics: F1 generation, time to parturition, which is defined as the number of days from vaginal plug identification to birth; F2 and F3 generations, the number of days from pairing to giving birth. Data are shown as mean ± SEM. A Student\'s t test was used to compare TCDD with vehicle groups for each endpoint within each generation.

F0 Exposure to TCDD Has Transgenerational Effects on the CD8^+^ T cell Response to IAV in the Lungs of Female F3 Offspring {#sec2.1}
--------------------------------------------------------------------------------------------------------------------------

IAV infects epithelial cells in the respiratory tract, and CD8^+^ T cells are the principle cell type responsible for viral clearance during acute primary infection. In particular, in the lung, virus-specific cytotoxic CD8^+^ T cells eliminate IAV infected cells ([@bib40], [@bib51], [@bib69]). To assess how F0 AHR activation affects the overall quality of the CD8^+^ T cell response to IAV across generations, we examined metrics of clonal expansion and effector function in F1 and F3 offspring. At maturity, female mice that were exposed developmentally (F1 generation offspring) or transgenerationally (F3 generation offspring) were infected with IAV. Nine days after infection, which is the peak day of this response ([@bib42], [@bib41]), the percentage and number of CD8^+^ T cells in the lungs of TCDD lineage offspring were significantly reduced in F1 generation offspring, but not in the F3 generation ([Table S1](#mmc1){ref-type="supplementary-material"}). The percentage of viral nucleoprotein (NP)-specific CD8^+^ T cells was reduced by about 60% in female mice that were developmentally exposed to TCDD ([Figure 2](#fig2){ref-type="fig"}A). Similarly, the number of NP^+^CD8^+^ T cells was significantly decreased in TCDD lineage F1 offspring compared with infected vehicle F1 offspring ([Figure 2](#fig2){ref-type="fig"}B). In the F3 generation, the percentage of NP^+^CD8^+^ T cells was not affected by F0 AHR activation ([Figure 2](#fig2){ref-type="fig"}C). However, F0 AHR ligand exposure caused a significant decrease in the number of NP^+^CD8^+^ T cells in the lungs of F3 female TCDD lineage offspring ([Figure 2](#fig2){ref-type="fig"}D). To assess how F0 AHR activation affects the overall magnitude of the CD8^+^ T cell response to IAV, we also determined the percentage and number of CTL (CD44^hi^CD62L^lo^CD8^+^ T cells), a population that includes NP-specific as well as CD8^+^ T cells specific for other viral peptide epitopes. In both the F1 and F3 generations, the proportion of CD8^+^ T cells that were CD44^hi^CD62L^lo^ was not influenced by F0 AHR activation ([Figures 2](#fig2){ref-type="fig"}E and 2G). However, the number of CTL was significantly reduced in F1 TCDD lineage offspring ([Figure 2](#fig2){ref-type="fig"}F) and 60% reduced in F3 offspring ([Figure 2](#fig2){ref-type="fig"}H). These results demonstrate that AHR activation in F0 dams has transgenerational effects on CD8^+^ T cell clonal expansion during the response to IAV.Figure 2F0 Exposure to TCDD Has Transgenerational Effects on the CD8^+^ T Response to IAV in the Lung of Female OffspringAt maturity (8--10 weeks of age) 7--9 female mice from each exposure group were infected with IAV, and the CD8^+^ T cell response in the lung was measured 9 days later.(A) Flow plots depict the mean percent of NP^+^CD8^+^ T cells in vehicle (left) and TCDD (right) F1 offspring.(B) The graph indicates the mean number of NP^+^CD8^+^ T cells in vehicle and TCDD F1 offspring.(C) Flow plots depict the mean percent of NP^+^CD8^+^ T cells in F3 vehicle (left) and TCDD (right) lineage offspring.(D) The mean number of NP^+^CD8^+^ T cells in F3 vehicle and TCDD lineage offspring.(E) The flow plots display the mean percent of CTL in vehicle (left) and TCDD (right) F1 offspring.(F) The mean number of CTL in vehicle and TCDD F1 offspring.(G) Flow plots depict the mean percent of CTL in F3 vehicle (left) and TCDD (right) lineage offspring.(H) The mean number of CTL in vehicle and TCDD lineage F3 offspring.(I) The flow plot depicts the mean percent of IFNγ^+^CD8^+^ T cells in the lung of F1 offspring.(J) The mean number of IFNγ^+^CD8^+^ T cells in the lung of F1 offspring.(K) The flow plots show the mean percent of IFNγ^+^CD8^+^ T cells in the lung of F3 offspring.(L) The mean number of IFNγ^+^CD8^+^ T cells in the lung of F3 offspring.(M) The flow plots depict the mean percent of CD107a^+^CD8^+^ T cells in the lung of F1 offspring.(N) The mean number of CD107a^+^CD8^+^ T cells in the lung of F1 offspring.(O) The flow plots depict the mean percent of CD107a^+^CD8^+^ T cells in F3 offspring.(P) The mean number of CD107a^+^CD8^+^ T cells in the lung of F3 offspring. Full gating strategy is depicted in [Figure S1](#mmc1){ref-type="supplementary-material"}. NP^+^CD8^+^ T cells were derived from the leukocyte gate; all others were generated from the CD8^+^ T cell gate ([Figure S1](#mmc1){ref-type="supplementary-material"}).Data are represented as mean ± SEM; \* denotes p ≤ 0.05 (Student\'s t test). The numerical values that correspond to the bar graphs as well as p values for each comparison are listed in [Table S1](#mmc1){ref-type="supplementary-material"}.

A successful CD8^+^ T cell response to IAV infection not only involves a significant increase in the magnitude of the CD8^+^ T cell population in the lung, but also indicates that the cells have gained their effector functions. These include secretion of antiviral cytokines and degranulation, which enable CD8^+^ T cells to kill IAV-infected cells and clear the infection. To assess how F0 TCDD exposure impacts CD8^+^ T cell effector function, we determined the frequency and number of CD8^+^ T cells that make the antiviral cytokine IFNγ and that express CD107a, which is an indicator of degranulation. In the F1 generation, IFNγ production by CD8^+^ T cells in the lung was largely unaffected by F0 AHR activation ([Figures 2](#fig2){ref-type="fig"}I and 2J). However, in the F3 offspring, there was a 50% decrease in the number of IFNγ^+^CD8^+^ T cells in the lung ([Figures 2](#fig2){ref-type="fig"}K and 2L). A similar pattern was observed for CD107a^+^CD8^+^ T cells: there were no significant differences in either the percentage or number of CD107a^+^CD8^+^ T cells between vehicle and TCDD lineage offspring in the F1 generation ([Figures 2](#fig2){ref-type="fig"}M and 2N). However, in the F3 generation, the number, but not proportion, of CD107a^+^CD8^+^ T cells was significantly reduced when the AHR was activated in F0 dams ([Figure 2](#fig2){ref-type="fig"}P and 2O ). Thus, our findings indicate that F0 exposure to the AHR agonist TCDD has transgenerational effects on both CD8^+^ T cell effector function and clonal expansion during IAV infection. Interestingly, the transgenerational effects appear more robust with regard to the reduction of clonal expansion than effector function, suggesting that these pathways may be differentially regulated by F0 AHR activation.

F0 Exposure to TCDD Has Developmental but Not Transgenerational Effects on the CD8^+^ T cell Response to IAV in the Lungs of Male Offspring {#sec2.2}
-------------------------------------------------------------------------------------------------------------------------------------------

In parallel to experiments performed using female mice, we measured the CD8^+^ T cell response in their male siblings in the F1 and F3 generations. F0 exposure did not significantly modify the percent of NP^+^CD8^+^ T cells in the lungs of male F1 or F3 offspring ([Figures 3](#fig3){ref-type="fig"}A and 3C, [Table S1](#mmc1){ref-type="supplementary-material"}). The number of NP^+^CD8^+^ T cells was reduced by 45% in the F1 generation ([Figure 3](#fig3){ref-type="fig"}B) but was not significantly different from vehicle lineage in the F3 generation ([Figure 3](#fig3){ref-type="fig"}D). The percentage of CTL in the lungs of TCDD lineage F1 offspring was reduced by approximately 75% compared with vehicle ([Figure 3](#fig3){ref-type="fig"}E). Likewise, the size of the CTL population was smaller in TCDD lineage F1 offspring compared with vehicle ([Figure 3](#fig3){ref-type="fig"}F). However, in F3 generation male TCDD lineage offspring, neither the percentage nor the number of CTL was affected by F0 exposure to TCDD ([Figures 3](#fig3){ref-type="fig"}G and 3H). In the F1 generation, the proportion of CD8^+^ T cells that produced IFNγ was increased by F0 AHR activation ([Figure 3](#fig3){ref-type="fig"}I); however, the number of IFNγ^+^CD8^+^ T cells was reduced in F1 TCDD lineage offspring ([Figure 3](#fig3){ref-type="fig"}J). In the F3 generation, however, the percentage of IFNγ^+^CD8^+^ T cells was not altered by F0 TCDD exposure ([Figure 3](#fig3){ref-type="fig"}K). Moreover, similar to the F1 generation, the number of IFNγ^+^CD8^+^ T cells was reduced by 60% in TCDD lineage offspring compared with vehicle ([Figure 3](#fig3){ref-type="fig"}L). F0 AHR activation had a minimal impact on the CD107a^+^CD8^+^ T cell population in lungs of male offspring. Specifically, the proportion of CD8^+^ T cells that expressed CD107a was not different in either F1 or F3 generation offspring ([Figures 3](#fig3){ref-type="fig"}M and 3O). The number of CD107a^+^CD8^+^ T cells in F1 generation offspring was reduced by 40% in offspring of TCDD-treated dams ([Figure 3](#fig3){ref-type="fig"}N); however, the number of CD107a^+^CD8^+^ T cells in TCDD F3 generation offspring was not different from vehicle F3 lineage mice ([Figure 3](#fig3){ref-type="fig"}P).Figure 3F0 Exposure to TCDD Has Developmental but Not Transgenerational Effects on the CD8^+^ T Response to IAV in the Lung of Male TCDD Lineage Offspring7--8 male mice from each treatment group were infected with IAV, and the CD8^+^ T cell response in the lung was measured 8 days later.(A) Flow plots depict the mean percent of NP^+^CD8^+^ T cells in vehicle (left) and TCDD (right) F1 offspring.(B) The mean number of NP^+^CD8^+^ T cells in vehicle and TCDD F1 offspring.(C) Flow plots depict the mean percent of NP^+^CD8^+^ T cells in F3 vehicle (left) and TCDD (right) lineage offspring.(D) The mean number of NP^+^CD8^+^ T cells in F3 vehicle and TCDD lineage offspring.(E) The flow plots display the mean percent of CTL in vehicle (left) and TCDD (right) F1 offspring.(F) The mean number of CTL in vehicle and TCDD F1 offspring.(G) Flow plots depict the mean percent of CTL in F3 vehicle (left) and TCDD (right) lineage offspring.(H) The mean number of CTL in vehicle and TCDD lineage F3 offspring.(I) The flow plot depicts the mean percent of IFNγ^+^CD8^+^ T cells in the lung of F1 offspring.(J) The mean number of IFNγ^+^CD8^+^ T cells in the lung of F1 offspring.(K) The flow plots show the mean percent of IFNγ^+^CD8^+^ T cells in the lung of F3 offspring.(L) The mean number of IFNγ^+^CD8^+^ T cells in the lung of F3 offspring.(M) The flow plots depict the mean percent of CD107a^+^CD8^+^ T cells in the lung of F1 offspring.(N) The mean number of CD107a^+^CD8^+^ T cells in the lung of F1 offspring.(O) The flow plots depict the mean percent of CD107a^+^CD8^+^ T cells in F3 offspring.(P) The mean number of CD107a^+^CD8^+^ T cells in the lung of F3 offspring. Full gating strategy is depicted in [Figure S1](#mmc1){ref-type="supplementary-material"}. NP^+^CD8^+^ T cells were derived from the leukocyte gate; all others were generated from the CD8^+^ cell gate ([Figure S1](#mmc1){ref-type="supplementary-material"}).Data are shown as mean + SEM; \* denotes p ≤ 0.05 (Student\'s t test). Numerical values for the bar graphs as well as p values that correspond to the comparisons in each panel are shown in [Table S1](#mmc1){ref-type="supplementary-material"}.

In summary, these results indicate that F0 exposure to TCDD affects important aspects of the CD8^+^ T cell response to IAV in the lungs of both male and female F1 offspring. However, in the F3 generation, F0 exposure had a minimal impact on the CD8^+^ T cell response to IAV in male offspring. Conversely, F0 exposure caused transgenerational effects on the CD8^+^ T cell response to infection in the lungs of female F3 offspring, findings that suggest that transgenerational inheritance in the immune system may be sex specific.

In the MLN, F0 AHR Activation Alters the CD8^+^ T cell Response of Female and Male F1 but Not F3 Generation Offspring {#sec2.3}
---------------------------------------------------------------------------------------------------------------------

Although the effector functions of CD8^+^ T cells to IAV infection are predominantly executed in the respiratory tract, their activation begins in the lymph nodes, where CD8^+^ T cells interact with antigen-presenting cells expressing viral peptides. This stimulates naive CD8^+^ T cells to clonally expand and differentiate into armed effectors before migrating to the lung. Therefore, we determined whether F0 TCDD exposure also caused transgenerational changes in CD8^+^ T cell clonal expansion or differentiation in the MLN in response to IAV infection. Across all metrics, maternal exposure reduced the CD8^+^ T cell response to IAV in the MLN of male and female F1 offspring. Thus, offspring of TCDD-treated dams exhibited significant reductions in the number of NP^+^CD8^+^ T cells ([Figures 4](#fig4){ref-type="fig"}A and 4E), CTL ([Figures 4](#fig4){ref-type="fig"}B and 4F), IFNγ^+^ ([Figures 4](#fig4){ref-type="fig"}C and 4G), and CD107a^+^CD8^+^ T cells ([Figures 4](#fig4){ref-type="fig"}D and 4H and [Table S2](#mmc1){ref-type="supplementary-material"}). Despite the strong effect that F0 AHR activation had on the CD8^+^ T cell response in F1 offspring, we did not observe any statistically significant differences in these measures of CD8^+^ T cell expansion or effector function in the MLN of male or female F3 offspring ([Figure 4](#fig4){ref-type="fig"}, [Table S2](#mmc1){ref-type="supplementary-material"}).Figure 4In the MLN, F0 AHR Activation Alters the CD8^+^ T Cell Response of Female and Male F1 but Not F3 Generation OffspringF1 and F3 generation offspring were generated as shown in [Figure 1](#fig1){ref-type="fig"}A. 7--9 adult F1 and F3 generation offspring from each treatment group were infected with IAV, and MLN cells were harvested on day 8 (males) or 9 (females) post infection. The graphs depict the mean number of cells from vehicle and TCDD offspring found in the MLN on day 8 or 9 post IAV infection.(A) The number of NP^+^CD8^+^ T cells in female F1 (left) and F3 (right) offspring.(B) The number of CTL in female F1 (left) and F3 (right) offspring.(C) The number of IFNγ^+^CD8^+^ T cells in female F1 (left) and F3 (right) offspring.(D) The number of CD107a^+^CD8^+^ T cells in female F1 (left) and F3 (right) offspring.(E) The number of NP^+^CD8^+^ T cells in male F1 (left) and F3 (right) offspring.(F) The number of CTL in male F1 (left) and F3 (right) offspring.(G) The number of IFNγ^+^CD8^+^ T cells in male F1 (left) and F3 (right) generation offspring.(H) The number of CD107a^+^CD8^+^ T cells in male F1 (left) and F3 (right) offspring. Black-striped bars, VEH F1; white-striped bars, TCDD F1; black bars, VEH F3; white bars, TCDD F3.Data are shown as mean +SEM. \* denotes p value ≤ 0.05 (Student\'s t test). Numerical values for all the bar graphs as well as p values for each comparison are shown in [Table S2](#mmc1){ref-type="supplementary-material"}.

Transgenerational Effects on the CD8^+^ T cell Response to IAV Are Transmitted through Both Parental Lineages {#sec2.4}
-------------------------------------------------------------------------------------------------------------

To determine whether the reduced CD8^+^ T cell responses in the lungs of female F3 generation offspring are preferentially transmitted through the maternal or paternal F1 lineage, we performed outcrosses of F1 mice. The outcrosses generated a group of offspring that had only maternal lineage TCDD exposure and another group of offspring with only paternal lineage TCDD exposure ([Figure 5](#fig5){ref-type="fig"}A). As controls, we also carried F1 siblings forward by incrossing F1 males and females from the same F0 exposure groups (i.e., F1 VEH x F1 VEH; F1 TCDD x F1 TCDD). At maturity, we infected F3 offspring from all four crosses and measured CD8^+^ T cell clonal expansion and effector function. Consistent with our prior observations ([Figure 2](#fig2){ref-type="fig"}D), in the F3 generation, the number of virus NP-specific CD8^+^ T cells was significantly decreased in the incrossed TCDD lineage relative to incrossed vehicle lineage offspring ([Figure 5](#fig5){ref-type="fig"}B, black and white bars). Maternal TCDD lineage exposure replicated the significant decrease ([Figure 5](#fig5){ref-type="fig"}B, black and light gray bars). Paternal lineage exposure also decreased the number of NP^+^CD8^+^ T cells, but the effect was not statistically significant ([Figure 5](#fig5){ref-type="fig"}B compare the black and dark gray bars; see also [Table S4](#mmc1){ref-type="supplementary-material"}). TCDD exposure through either the paternal or maternal lineage significantly reduced the number of CTL ([Figure 5](#fig5){ref-type="fig"}C). The average number of IFNγ^+^CD8^+^ T cells was not significantly different among the outcrossed groups and control; however, the two incrossed groups were significantly different ([Figure 5](#fig5){ref-type="fig"}D, [Table S4](#mmc1){ref-type="supplementary-material"}). Similar to viral NP-specific CD8^+^ T cells, the number of CD107a^+^CD8^+^ T cells was significantly reduced in both the TCDD incrossed and maternal lineages, whereas paternal TCDD lineage exposure caused a subtler decrease in the number of CD107a^+^CD8^+^ T cells, which did not reach statistical significance ([Figure 5](#fig5){ref-type="fig"}E). When considered together, these changes in CD8^+^ T cell clonal expansion and effector function do not appear to be transmitted solely through a single parental lineage, as F3 effects were observed in both the maternal and paternal TCDD lineage exposures separately. Although both F1 parental lineages affected the CD8^+^ T cell response to IAV in the F3 generation, these data suggest that exposure through the maternal line had a more potent effect on the CD8^+^ T cell response than paternal lineage TCDD exposure and that clonal expansion may be more sensitive to the effects of F0 AHR activation than acquisition of CTL effector function.Figure 5Transgenerational Effects on the CD8^+^ T Cell Response to IAV in the Lung Are Transmitted through Both Parental Lineages(A) Outcross breeding scheme: F1 offspring were generated as in [Figure 1](#fig1){ref-type="fig"}A. A portion of F1 offspring from both vehicle and TCDD treatment groups was used to perform outcrosses. Vehicle males were paired with TCDD females to create the maternal TCDD lineage. For the paternal TCDD lineage, vehicle females were paired with TCDD males. Vehicle x vehicle and TCDD x TCDD incrosses were also made. The resulting F2 offspring were paired to other non-sibling F2 offspring to create the F3 generation. At 8--10 weeks of age, 7--9 male and 7--9 female offspring from different dams were infected with IAV. MLNs and lungs from males were harvested on day 8 post infection and from females on day 9.(B--E) The CD8^+^ T cell response in the lung of female F3 outcrossed offspring. The designations to the left of each graph denote the F0 treatment group of the male and female F1 offspring involved in each F1 cross. The graphs depict the mean number of cells found in the lung of F3 female offspring: (B) NP^+^CD8^+^ T cells, (C) CTL, (D) IFNγ^+^CD8^+^ T cells, and (E) CD107a^+^CD8^+^ T cells. Black bars, VEH; white bars, TCDD; light gray bars, maternal TCDD lineage; dark gray bars, paternal TCDD lineage.Data are shown as mean ± SEM. \* denotes p value ≤ 0.05 determined by a two-way ANOVA followed by a Dunnett\'s test with the control as the VEH x VEH lineage. The numerical values for the bar graphs are listed in [Table S3](#mmc1){ref-type="supplementary-material"}, and the p values generated using two-way ANOVA and Dunnett\'s test are shown in [Table S4](#mmc1){ref-type="supplementary-material"}. The outcross experiment was performed once.

Developmental AHR Activation Influences the CD8^+^ T cell Response to Infection via Targeting Hematopoietic Cells {#sec2.5}
-----------------------------------------------------------------------------------------------------------------

The AHR is widely expressed in hematopoietic and non-hematopoietic cells. To determine whether AHR signaling within the hematopoietic compartment contributes differentially to the effects of developmental exposure in the CD8^+^ T cell responses of female and male offspring, we used conditional knockout mice that lack *Ahr* in all hematopoietic cells ([@bib4]). To create littermates that do and do not express the *Ahr* in hematopoietic cells, we crossed nulliparous *Ahr*^*fx/fx*^ females with *Ahr*^*fx/fx*^*Vav1*^*cre*^ male mice. The resulting male and female *Ahr*^*fx/fx*^ and *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring of control or TCDD-treated dams were infected with IAV at maturity. Similar to wild-type B6 mice, female *Ahr*^*fx/fx*^ F1 offspring that were developmentally exposed to TCDD exhibited reduction in the percentage ([Figure 6](#fig6){ref-type="fig"}A) and number ([Figure 6](#fig6){ref-type="fig"}B) of NP^+^CD8^+^ T cells compared with vehicle-exposed *Ahr*^*fx/fx*^ mice. However, when *Ahr* was excised from hematopoietic cells, maternal exposure did not affect the number of NP^+^CD8^+^ T cells in female offspring ([Figure 6](#fig6){ref-type="fig"}B). Although there was no difference in the percentage ([Figure 6](#fig6){ref-type="fig"}C), infected male *Ahr*^*fx/fx*^ offspring of dams treated with TCDD had a statistically significant reduction in the number of NP^+^CD8^+^ T cells compared with male *Ahr*^*fx/fx*^ offspring of vehicle control dams ([Figure 6](#fig6){ref-type="fig"}D). Yet, the number of NP^+^CD8^+^ T cells in TCDD exposed *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring was not significantly different from that of *Vav1*^*cre*^*Ahr*^*fx/fx*^ male offspring of control dams ([Figure 6](#fig6){ref-type="fig"}D). Thus, the decreased number of NP^+^CD8^+^ T cells in TCDD-exposed F1 offspring requires AHR-mediated signaling in the hematopoietic cells. In addition to measuring the expansion of virus-specific CD8^+^ T cells, we compared differentiation into CTL. Regardless of maternal exposure, the percentage of CTL was similar in female *Ahr*^*fx/fx*^ and *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring ([Figure 6](#fig6){ref-type="fig"}E). Yet, compared with female offspring of control-treated dams, there was a statistically significant reduction in the number of CTL in female *Ahr*^*fx/fx*^ mice that were developmentally exposed to TCDD ([Figure 6](#fig6){ref-type="fig"}F). Lack of *Ahr* in hematopoietic cells eliminated this difference in the number of CTL ([Figure 6](#fig6){ref-type="fig"}F). In IAV-infected male offspring, there was also no significant difference in the percentage of CTL ([Figure 6](#fig6){ref-type="fig"}G), but the number of CTL in TCDD-exposed *Ahr*^*fx/fx*^ males was significantly less than in vehicle-exposed *Ahr*^*fx/fx*^ offspring ([Figure 6](#fig6){ref-type="fig"}H). When *Vav1*^*cre*^*Ahr*^*fx/fx*^ TCDD-exposed offspring were infected, the number of CTL was not significantly different from that of *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring ([Figure 6](#fig6){ref-type="fig"}H). However, similar to NP^+^CD8^+^ T cells from *Vav1*^*cre*^*Ahr*^*fx/fx*^ males, the number of CTL was 1.7-fold lower in TCDD-exposed offspring compared with males of vehicle-treated dams means. Thus, when the AHR is triggered during development, it effects hematopoietic cells in a manner that leads to changes in CD8^+^ T cell responses later in life, although the consequences may be slightly different between sexes.Figure 6Lack of AHR in Hematopoietic Cells Has Differential Effects on CD8+ T Cell Expansion in Female and Male Offspring during IAV InfectionAt maturity, 9--11 male or female developmentally exposed *Vav1*^*cre*^*Ahr*^*fx/fx*^ and *Ahr*^*fx/fx*^ offspring were infected with IAV. MLN cells were harvested and stained as described in the [Transparent Methods](#mmc1){ref-type="supplementary-material"} section.(A) The percentage of NP^+^CD8^+^ T cells in IAV-infected female vehicle and TCDD-exposed *Ahr*^*fx/fx*^ (top row) and *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring (bottom row). The number on the plots denotes the mean percentage of NP^+^CD8^+^ T cells.(B) The number of NP^+^CD8^+^ T cells from vehicle (V) and TCDD (T)-exposed *Ahr*^*fx/fx*^ and *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring on day 9 post IAV infection.(C) The percentage of NP^+^CD8^+^ T cells in male exposed *Ahr*^*fx/fx*^ and *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring on day 9 post IAV infection.(D) The number of NP^+^CD8^+^ T cells from male *Ahr*^*fx/fx*^ and *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring of vehicle and TCDD treated dams.(E) The percentage of CTL (CD44^hi^CD62L^lo^CD8^+^ T cells) in female *Ahr*^*fx/fx*^ (top row) and *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring (bottom row) on day 9 post IAV infection. The number on the plots denotes the mean percentage of CTL.(F) The number of CD44^hi^CD62L^lo^ CD8^+^ T cells in female *Ahr*^*fx/fx*^ and *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring.(G) The percentage of CTL in male *Ahr*^*fx/fx*^ (top row) and *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring (bottom row). The number on the plots denotes the mean percentage of CTL.(H) The number of CTL in male *Ahr*^*fx/fx*^ and *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring 9 days after infection. All flow plots are derived from the CD8^+^ T cell gate ([Figure S1](#mmc1){ref-type="supplementary-material"}).All data are presented as mean ± SEM. \* denotes p value ≤0.05, compared with control offspring with the same genotype (ANOVA followed by Tukey HSD).

Discussion {#sec3}
==========

Recent studies reveal that maternal exposures can cause changes in biological processes that span generations. For example, maternal exposure to endocrine disrupting chemicals causes transgenerational changes in metabolism as well as altered reproductive and nervous system functions ([@bib29], [@bib64], [@bib66], [@bib72], [@bib73], [@bib79], [@bib83]). Other studies have shown that maternal and early life exposures affect immune responses in the F1 generation ([@bib10], [@bib84]). Although a recent study indicates that maternal exposure to diesel exhaust particles affects asthma risk across generations ([@bib27]), no prior studies have directly examined whether maternal exposure to AHR-binding chemicals causes transgenerationally inherited changes in immune responses. The work reported in the present study evaluated whether maternal (F0) exposure affects a key immune defense in a transgenerational manner. We found that F0 exposure caused transgenerational effects on the CD8^+^ T cell response to influenza A virus infection; however, not all of the effects observed in the F1 generation were transmitted equally to the F3 generation, and the transgenerational effects observed were organ and sex specific.

The major finding of our study was that F0 exposure to TCDD caused transgenerational changes to the CD8^+^ T cell response to infection. Interestingly, changes in the F3 generation were observed in the infected lung but not in the MLN. This is in contrast to the F1 generation, in which the T cell response to infection is altered in both MLN and lung. Although the site of IAV infection is the respiratory tract, the MLN is the primary site where naive CD8^+^ T cells become activated, clonally expand, differentiate, and acquire effector functions before migrating to the lung. In addition to recognizing and eliminating infected cells in the lung, newly emigrated CD8^+^ T cells can also receive additional signals from lung resident DCs. This provides greater stimulation to the CD8^+^ T cells, prompting them to undergo additional rounds of proliferation and enhancing their cytotoxicity ([@bib51]). As such, DC-CD8^+^ T cell interactions in the lung are important for an optimally effective CD8^+^ T cell response to IAV ([@bib43], [@bib52]). Thus, a possible explanation for transgenerational differences in the CD8^+^ T cell response in the lung, but not the MLN, is that there are durable effects of F0 exposure on DC functions that bolster CD8^+^ T cell responses in the infected lung. A recent report demonstrates that developmental exposure to TCDD alters DC function in adult F1 offspring, including their ability to activate naive IAV-specific CD8^+^ T cells ([@bib53]). Other studies provide further evidence that early life exposures influence the function of DCs. For example, offspring of dams sensitized with ovalbumin or diesel exhaust particles (DEPs) are predisposed to airway inflammation later in life, in part due to changes in DCs, and some effects of DEP exposure span generations ([@bib21], [@bib27]). Thus, changes in DC function potentially carry across generations.

In addition to influencing leukocyte functions, F0 exposure may trigger changes to the programming of lung epithelial cells, and the consequences of this may differ across generations in a manner that influences the quality of the CD8^+^ T cell response in the infected lung. For example, lung epithelial cells produce thymic stromal lymphopoietin (TSLP), a cytokine that, when produced during an IAV infection, acts on DCs in the lung and enhances the DC-CD8^+^ T cell interactions necessary for continued expansion of CD8^+^ T cells ([@bib87]). Furthermore, activation of the AHR influences *Tslp* gene expression ([@bib35]). Therefore, it is possible that the reduced CD8^+^ T cell response in the lung is due to ineffective DC-CD8^+^T cell interactions, which arise from changes to the DCs themselves and also from aberrant signaling from the lung epithelium that is programmed by F0 AHR activation.

Another important observation in our study was that the transgenerational effects were sex specific. This was somewhat surprising given that in the F1 generation both male and female offspring of TCDD-treated dams had significantly suppressed CD8^+^ T cell responses to IAV infection. Yet, in the F3 generation, differences in these same metrics of the CD8^+^ T cell response to infection were observed in female offspring but not in their male littermates. A simple explanation is that immunomodulatory programming is passed on only maternally. However, results from the outcross experiment indicate that there are consequences of F0 AHR activation in male F1 offspring that contribute to generation-spanning changes in T cell responses. Specifically, paternal lineage TCDD exposure transmitted altered CD8^+^ T cell responses to female F3 offspring. The difference in the consequences of F0 exposure in the male F1 and F3 generation could indicate that direct (F0, F1) and indirect (F3) exposures have differential effects on programming in the male germ line. AHR activation by TCDD affects the male and female reproductive system ([@bib13], [@bib15], [@bib37], [@bib50]), and the AHR is broadly expressed in many tissues, including immune and non-immune cells. Within the developing hematopoietic system, the *Ahr* is expressed in fetal liver and thymus and is transcriptionally active. For instance, AHR activation stimulates *Cyp1a1* gene expression in fetal liver, hematopoietic stem and progenitor cells, thymus, and also peripheral T cells of neonatal mice that were directly exposed to TCDD ([@bib1], [@bib49], [@bib70], [@bib85]). Yet, the transcriptional activity triggered by early life exposure is transient, as evidenced by the observation that, in adult offspring exposed perinatally, the AHR activity induced by earlier exposure does not persist ([@bib24], [@bib33], [@bib85]). Although the mechanisms by which triggering the AHR lead to generation-spanning alterations in immune function remain to be elucidated, these results suggest that direct exposures (F0, F1) may lead to immunomodulatory effects that are easily discernable but are transient, whereas indirect effects are more subtle. Variations in AHR-mediated changes in gene expression in distinct cell types, as well as in developing male and female fetuses and neonates, may underlie some of the differences observed in our study. Based on a combination of mRNA and protein expression, different cells and tissues express different levels of the *Ahr* ([@bib20], [@bib46], [@bib60]). For example, the lung and liver generally express higher levels compared with immune cells ([@bib46]). When it has been compared directly, male and female rodents express the *Ahr* at similar levels ([@bib44], [@bib57]). A limitation of current knowledge is that, in many studies of *Ahr* expression and AHR signaling, only one sex has been used. Moreover, in fetal tissues, sex is generally not reported, perhaps owing to technical challenges, such as the need to pool tissue from more than one fetus to obtain sufficient material for assays. Nonetheless, distinct consequences of *direct* exposure to TCDD in male and female mice have been described ([@bib44], [@bib62], [@bib63]). For instance, *Ahr* expression levels and induction of known AHR target genes were similar in male and female mice, whereas TCDD treatment elicited changes to the overall transcriptome profile in liver that were different in males and females ([@bib44], [@bib63]). Also, the immune responses of both males and females are similarly influenced by direct exposure to AHR agonists, whereas differences in the magnitude have been observed, although which sex is more sensitive (i.e., showed significant effect at lower dose) depended on the antigen challenge ([@bib56], [@bib77], [@bib82]). Therefore, different levels of *Ahr* within a particular cell or tissue are not likely sufficient to explain differential responses. Instead, differences reflect a combination of the manner in which AHR signaling converges with other signaling pathways that are specific to cell type and sex and, in the case of immune responses, the specific antigen challenge.

Further support for the idea that the observed consequences of developmental and transgenerational exposures reflect complex interplay comes from our finding that the effects of developmental exposure were not identical in male and female offspring. For instance, in female *Vav1*^*cre*^*Ahr*^*fx/fx*^ offspring, excision of *Ahr* from hematopoietic cells fully eliminated the effect of maternal TCDD treatment on the response to IAV. In male *Vav1*^*cre*^*Ahr*^*fx/fx*^ mice, the effect appeared blunted, suggesting that in males there may be hematopoietic and non-hematopoietic effects of developmental exposure that contribute to the attenuated CD8^+^ T cell response. The AHR is expressed widely throughout the body and is highly expressed in barrier organs such as the lung ([@bib20]). Therefore, it is possible that AHR activation in non-hematopoietic cells, such as developing lung epithelial cells, sets off an alternative programming that indirectly affects the CD8^+^ T cell response to infection in male TCDD-exposed offspring. A related potential explanation is that sex differences in the immune response to infection contribute to the observed differences. Although the overall cellular and molecular defense mechanisms are the same, there are differences in the timing and magnitude of the immune response to IAV in males and females ([@bib80]). For example, during a primary IAV infection, females generally mount adaptive immune responses that are larger in magnitude, yet males have less mortality than females ([@bib38]). However, during secondary challenge with a heterosubtypic virus, females have lower viral titers in their lungs, which is thought to be due to their greater ability to produce antibodies than males ([@bib23], [@bib47]). The mechanisms that explain sex differences in the response to IAV are not completely understood; however, steroid sex hormones are a contributing factor ([@bib67]). Given that AHR signaling influences endocrine tissues and endocrine-mediated pathways, it is likely that F0 AHR activation affects myriad different pathways that could potentially influence the programming and function of the immune system.

Although the totality of mechanisms that drive transgenerational inheritance are not fully known, changes in epigenetic regulatory marks are one of the means for conveying changes across generations. Non-coding RNA and histone marks are increasingly recognized as facilitators; however, DNA methylation has been the focus of many studies of transgenerational inheritance ([@bib3], [@bib6], [@bib8], [@bib59]). Several pieces of evidence link developmental exposure to the AHR agonist TCDD with altered DNA methylation in transgenerational inheritance of disease phenotypes. For example, in a transgenerational study using rats, developmental exposure to TCDD caused differentially methylated regions (DMRs) in the promoters of sperm DNA isolated from F3 offspring ([@bib50]). Developmental exposure to TCDD also altered DNA methylation in the female reproductive tract ([@bib16]). A comparison of progesterone receptor (PR) methylation levels in female offspring revealed that developmental TCDD exposure caused durable hypermethylation of the PR gene ([@bib16]). Specifically, in F1 offspring developmentally exposed to TCDD, the PR gene was 60% hypermethylated compared with control offspring, and it remained 40% hypermethylated in F3 offspring ([@bib16]). Furthermore, in preimplantation embryos treated with TCDD, there was a reduction in gene expression of the imprinted gene *H19* that corresponded with an increase in DNA methylation and increased methyltransferase activity ([@bib86]). Another study found that male F1 and F3 rats developmentally exposed to TCDD had altered levels of DNMT3a and DNMT3b in liver tissue ([@bib48]). Hence, there is evidence that developmental exposure to TCDD alters DNA methylation patterns in F1 and F3 offspring. Additionally, separate studies have shown that developmental exposure of mice to TCDD alters DNA methylation patterns in CD8^+^ T cells in F1 offspring ([@bib85]). DMRs were observed across all genomic features in CD8^+^ T cells from IAV-infected and from naive mice, suggesting that F0 TCDD exposure influences DNA methylation marks in T cells. In contrast to the liver, changes in overall DNA methylation in CD8^+^ T cells were not associated with alterations in *Dnmt* expression levels ([@bib85]). This suggests that, in CD8^+^ T cells, changes in DNA methylation levels may not be mediated by direct modulation of DNMT expression or that developmental exposure is causing broad changes in the cellular machinery that regulates DNA methylation. Nonetheless, these overall findings indicate that altered DNA methylation likely plays an important role in shaping how exposures in the womb and shortly after birth mold the immune system\'s function later in life, and potentially across generations.

Few studies of transgenerational inheritance have examined the effects of environmental exposures on the immune system, and no prior studies of developmental exposure to AHR agonists have examined transgenerational effects on immune cells. The work presented here demonstrates that the immune system, like other organ systems, is vulnerable to transgenerational effects caused by environmental exposures. These studies also emphasize the importance of examining both sexes and considering that differences at the site of infection and secondary lymphoid organs may not always be the same. The discovery that maternal exposure to an AHR agonist caused effects on T cells that persisted across generations expands our knowledge of how developmental exposures impact the immune system. Given that early life exposure to environmental chemicals that bind AHR is associated with greater incidence and severity of infectious disease in human populations, the broad implications of these new findings indicate that environmental cues have a tremendous impact on public health, not just in the present but also for future generations.

Limitations of the Study {#sec3.1}
------------------------

Although we report novel and exciting findings about transgenerational effects in the immune system, only a single immune challenge was used. This constrains conclusions about sex specificity and whether T cell responses in other peripheral tissues would also be affected across generations. Future studies with additional immune challenges, such as other types of viruses and assessment of antitumor immunity (which also requires CD8^+^ T cells), will be important extensions of this work.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Code Availability {#appsec1}
==========================

All the FCS (flow cytometry standard) files used to generate the data in this paper, as well as FCS files from an independent transgenerational cohort, has been deposited in the NIH FigShare repository (DOI: <http://doi.org/10.35092/yhjc.c.4649441>)
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